Latest Financial Position News

Trigg Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant capital raise, signaling potential shifts in its financial strategy.

Investigator Resources appoints Lachlan Wallace as Managing Director and secures $4.3 million to accelerate exploration at the Paris Silver Project and beyond.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

Norwood Systems has extended the repayment date on its key loan facility to July 31, 2025, with the principal reduced to $318,341 following significant repayments. This move supports the company’s ongoing growth initiatives, including its recent Optus contract win.

Future Battery Minerals has revealed significant shallow gold intercepts and broad surface anomalies at its Burbanks East Project, with drilling at the nearby Miriam Project scheduled to start in July 2025.

Laramide Resources has announced a $10 million private placement to fund critical US permitting and corporate activities, with major shareholder Boss Energy backing the raise.

The Star Entertainment Group updates investors on stalled negotiations with its joint venture partners over the Destination Brisbane Consortium transaction, facing a looming termination of their binding agreement.

Horseshoe Metals Limited has requested a voluntary suspension of its shares on the ASX to complete a capital raising, with trading expected to resume by 1 July 2025.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project in Southern Spain by 160%, adding three new permits and preparing for a targeted drilling campaign to confirm mineral continuity.

Gateway Mining Limited has agreed to acquire Strickland Metals’ Yandal Gold Project for $45 million in shares, adding a 400,400-ounce inferred gold resource to its portfolio. The deal, pending shareholder approvals, sets the stage for accelerated exploration and development in Western Australia’s prolific goldfields.

South Harz Potash Ltd has announced a pro-rata non-renounceable entitlement issue to raise approximately A$1.28 million, offering one new share for every three held plus free options. The capital raise aims to fund its dual-asset growth plans in Germany amid ongoing project development and acquisition efforts.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.